Increased physiological dead space at exercise is a marker of mild pulmonary or cardiovascular disease in dyspneic subjects
- PMID: 30627360
- PMCID: PMC6314086
- DOI: 10.1080/20018525.2018.1492842
Increased physiological dead space at exercise is a marker of mild pulmonary or cardiovascular disease in dyspneic subjects
Abstract
Background: The characteristics of cardiopulmonary exercise testing (CPET)-derived parameters for the differential diagnosis of exertional dyspnea are not well known. Objectives: We hypothesized that increased physiological dead space ventilation (VD/Vt) is a marker for mild pulmonary or cardiovascular disease in patients with exertional dyspnea. Design: We used receiver operating characteristic analysis to determine the performance of individual CPET parameters for identifying subjects with either mild pulmonary or cardiovascular disease, among 77 subjects with mild-to-moderate exertional dyspnea (modified Medical Research Council scale 1-2). Results: In comparison with subjects without disease, subjects with pulmonary disease (n = 31) had higher VE/V'CO2 slope, higher VD/Vt, and lower ventilatory reserve. Subjects with cardiovascular disease (n = 14) had lower heart rate and cardiovascular double product and higher VD/Vt at peak exercise. At a threshold of 28%, the sensitivity and specificity of VD/Vt at peak exercise for identifying pulmonary or cardiovascular disease were 89% (95% CI: 64-98%) and 72% (95% CI: 46-89%), respectively. Conclusions: Increased physiological VD/Vt at exercise is a sensitive and specific marker of mild pulmonary or cardiovascular disease in dyspneic subjects.
Keywords: Dead space; cardiopulmonary exercise testing; cardiovascular disease; efficiency; exercise; lung disease.
Figures
References
-
- American Thoracic Society, American College of Chest Physicians ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–8. - PubMed
-
- Arena R, Sietsema KE.. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation. 2011;123:668–680. - PubMed
-
- O’Donnell DE, Ora J, Webb KA, et al. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol. 2009;167:116–132. - PubMed
-
- Flaherty KR, Wald J, Weisman IM, et al. Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med. 2001;164:425–432. - PubMed
-
- Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation. 2002;106:319–324. - PubMed
LinkOut - more resources
Full Text Sources